Topic Highlight
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jan 28, 2016; 22(4): 1357-1366
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1357
Figure 1
Figure 1 Liver biopsy with cholestasis, mild portal and lobular inflammation, and apoptotic bodies. Hematoxylin and eosin stain, magnification × 100.
Figure 2
Figure 2 Lymphocyte predominant portal inflammation and a damaged bile duct (Poulsen Christofferson lesion). Periportal hepatocytes show ballooning/feathery degeneration. Hematoxylin and eosin stain, magnification × 200.
Figure 3
Figure 3 Portal and periportal fibrosis in a patient with concurrent human immunodeficiency virus and acute hepatitis C infection. Hematoxylin and eosin stain, magnification × 100.
Figure 4
Figure 4 Fibrous septa with lymphocyte predominant inflammatory infiltrates and multiple lymphoid aggregates, in a patient with cirrhosis secondary to hepatitis C. Hematoxylin and eosin stain, magnification × 40.
Figure 5
Figure 5 Portal lymphoid aggregate and lymphoplasmacytic inflammation with severe interface hepatitis, indicative of an overlap syndrome of autoimmune hepatitis and hepatitis C. Hematoxylin and eosin stain, magnification × 100.
Figure 6
Figure 6 Small clusters of lobular macrophages containing periodic acid Schiff positive-diastase resistant cytoplasmic debris. Periodic acid Schiff with diastase stain, magnification × 200.
Figure 7
Figure 7 Portal lymphoid aggregate and lymphoplasmacytic inflammation with interface hepatitis and occasional apoptotic hepatocyte at the portal-periportal interface. Hematoxylin and eosin stain, magnification × 200.
Figure 8
Figure 8 Portal tract with lymphoplasmacytic inflammation, and enclosing small clusters of hepatocytes indicative of recent episode of active hepatitis. Hematoxylin and eosin stain, magnification × 200.
Figure 9
Figure 9 Spotty necrosis characterized by small foci of lobular necroinflammation and associated apoptotic hepatocytes. Hematoxylin and eosin stain, magnification × 200.
Figure 10
Figure 10 Cirrhosis characterized by bridging fibrosis with nodule formation. Masson’s trichrome stain, magnification × 40.
Figure 11
Figure 11 Fibrosing cholestatic hepatitis with mixed portal inflammation, bile duct damage, interface hepatitis, ductular reaction and fibrosis. Hematoxylin and eosin stain, magnification × 100 (A); and extensive pericellular and perisinusoidal fibrosis (B; Trichrome stain, magnification × 100).